Neosil raises $10M in debt for hair-growth product
Neosil, an Emeryville, Calif., company focused on dermatology products, raised a $10 million in venture debt from Hercules Technology Growth Capital. The debt funding follows the company’s $32 million first-round venture financing in 2004, which involved MPM Capital and Burrill & Co.
Neosil is developing a peptide-based hair-growth product for male pattern baldness and a topical antimicrobial treatment. It describes the debt financing here.
Next Story: Light Sciences Oncology, IPO on hold, raises $15M
Previous Story: Amicus Therapeutics aims for potentially disruptive $92M IPO
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
VB Writers
Ben PopperEast Coast Editor
Dean TakahashiLead Writer, GamesBeat
Devindra HardawarNational Editor, MobileBeat Lead
Dylan TweneyExecutive Editor
ShoeEditor-in-Chief, GamesBeat
Heather KellySenior Editor
Jennifer Van GroveWriter
Jolie O'DellWriter
Matt MarshallFounder & Editor-in-Chief
Meghan KellyWriter
Sarah MitroffEditorial Assistant
Sean LudwigWriter
Sebastian HaleyReviews Editor, GamesBeat
Tom CheredarWriter
Ciara ByrneContributor
Julia PlevinContributor
Lindsey ComptonContributor
